IRIS
TOSCANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.478
AS - Asia 8.498
EU - Europa 8.275
SA - Sud America 3.459
AF - Africa 250
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 33.979
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.206
SG - Singapore 3.719
BR - Brasile 3.035
IE - Irlanda 2.396
CN - Cina 2.260
SE - Svezia 1.594
HK - Hong Kong 1.173
IT - Italia 974
DE - Germania 811
UA - Ucraina 508
VN - Vietnam 473
FI - Finlandia 458
RU - Federazione Russa 386
PL - Polonia 369
GB - Regno Unito 261
IN - India 216
AR - Argentina 144
FR - Francia 124
CA - Canada 122
MX - Messico 91
BD - Bangladesh 86
EC - Ecuador 83
NL - Olanda 79
TR - Turchia 77
BE - Belgio 76
ZA - Sudafrica 75
ID - Indonesia 68
AT - Austria 66
IQ - Iraq 59
JP - Giappone 50
CO - Colombia 48
MA - Marocco 46
PY - Paraguay 41
VE - Venezuela 41
UZ - Uzbekistan 39
PK - Pakistan 35
ES - Italia 32
KE - Kenya 30
TN - Tunisia 27
IR - Iran 24
LT - Lituania 24
PE - Perù 23
CI - Costa d'Avorio 22
CZ - Repubblica Ceca 22
JO - Giordania 21
AZ - Azerbaigian 20
CL - Cile 19
IL - Israele 19
KZ - Kazakistan 18
NP - Nepal 16
EG - Egitto 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
UY - Uruguay 14
DO - Repubblica Dominicana 13
HR - Croazia 13
JM - Giamaica 13
AL - Albania 12
KR - Corea 12
OM - Oman 12
BO - Bolivia 9
CR - Costa Rica 9
KG - Kirghizistan 9
LB - Libano 9
SA - Arabia Saudita 9
RS - Serbia 8
AU - Australia 7
CH - Svizzera 7
DK - Danimarca 6
EU - Europa 6
GR - Grecia 6
LV - Lettonia 6
PA - Panama 6
SN - Senegal 6
TH - Thailandia 6
AM - Armenia 5
BG - Bulgaria 5
HN - Honduras 5
KW - Kuwait 5
LK - Sri Lanka 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
HU - Ungheria 4
KH - Cambogia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
QA - Qatar 4
RO - Romania 4
SY - Repubblica araba siriana 4
AO - Angola 3
BH - Bahrain 3
CY - Cipro 3
GA - Gabon 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PH - Filippine 3
Totale 33.942
Salva come PNG Salva come JPEG
Città #
Dublin 2.394
Dallas 2.129
Singapore 1.531
Chandler 1.483
Ashburn 1.439
Hong Kong 1.173
Jacksonville 1.126
Nyköping 1.019
Beijing 909
Princeton 441
Medford 406
Los Angeles 389
Warsaw 360
Messina 336
Cambridge 330
The Dalles 328
Des Moines 311
Dearborn 308
Ann Arbor 285
New York 244
São Paulo 227
Buffalo 193
Munich 174
Ho Chi Minh City 163
Moscow 154
Wilmington 151
Boardman 139
Jinan 115
San Mateo 113
Shenyang 106
Redondo Beach 104
Tianjin 102
Hanoi 92
Rio de Janeiro 88
Nanjing 80
Belo Horizonte 73
Hyderabad 71
Turku 70
Ningbo 68
Rome 64
Houston 63
Brasília 60
Brooklyn 55
Helsinki 55
Zhengzhou 55
Brussels 51
Hebei 51
Woodbridge 51
Bremen 50
Curitiba 50
Frankfurt am Main 50
Santa Clara 49
Seattle 47
Hangzhou 46
Nuremberg 46
Tokyo 46
Johannesburg 44
San Francisco 43
Falls Church 42
Pune 41
Denver 40
Campinas 39
Taizhou 39
Jakarta 37
Dong Ket 36
Lancaster 36
Montreal 34
Porto Alegre 34
Vienna 34
Guayaquil 33
Haikou 33
Tashkent 33
Atlanta 32
Council Bluffs 32
Guangzhou 32
Stockholm 32
Chennai 31
London 31
Salvador 31
Fuzhou 29
Manaus 29
Nairobi 29
Nanchang 29
Boston 28
Milan 28
Fortaleza 27
Guarulhos 26
Amsterdam 25
Catania 25
Phoenix 25
Toronto 25
Changsha 24
Chicago 24
Orem 24
Taiyuan 24
Ankara 23
Mexico City 23
Ottawa 23
Quito 23
Waanrode 23
Totale 21.468
Salva come PNG Salva come JPEG
Nome #
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 253
The relationship between sleep quality and ratio of house size/number of people in chronic migraineurs during Covid-19 lockdown. 236
Severe rhabdomyolysis in a patient with “Heat Stroke” 236
Clinical and pathological features of focal myositis 225
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 217
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 190
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 177
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 152
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 151
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 151
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 149
A cytochemical study of apoptosis in metabolic myopathies 145
Atypical posterior reversible encephalopathy syndrome with hemispheric brainstem and spinal cord involvement in a patient with acute kidney injury – a case report. 142
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 141
A life threatening case of β-enolase deficiency 141
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 141
Community-acquired enterococcal meningitis caused by Enterococcus casseliflavus: first case report 137
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 135
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 134
Deficit multiplo di Acyl-CoA deidrogenasi responsivo alla riboflavina (MADD-RR): studio clinico, biochimico, genetico e spettroscopico 133
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 133
Auditory system involvement study in 20 patients with late-onset Pompe disease 133
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 133
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 131
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 131
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 130
A case of vacuolar myopathy during the course of chronic hepatitis C. 129
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 126
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 125
A benign case of congenital myotonic dystrophy 124
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 123
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 123
Pimozide and pancreatic cancer in diabetic chorea: a case report 122
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 120
Variants of the circle of Willis in ischemic stroke patients 120
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 119
Analysis of lipid profile in lipid storage myopathy 119
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 118
ANT1 is reduced in sporadic inclusion body myositis. 118
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 117
Syndromic parkinsonism and dementia associated with OPA1 missense mutations 116
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 115
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 115
Autoimmune juvenile limb-girdle myasthenia 115
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 114
Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum 113
A study of auditory system in 20 patients with late onset Pompe disease 112
211th ENMC International Workshop:: Development of diagnostic criteria and management strategies for McArdle Disease and related rare glycogenolytic disorders to improve standards of care. 17–19 April 2015, Naarden, The Netherlands 112
Ischemic stroke and reperfusion therapies in diabetic patients 112
Apoptosis and apoptosis-related proteins in thyroid myopathies 111
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 111
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 111
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 110
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 109
Juvenile limb-girdle myasthenia gravis 109
Miopatie metaboliche 109
208th ENMC International Workshop: Formation of a European Network to develop a European data sharing model and treatment guidelines for Pompe disease. 109
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 109
Auditory system involvement study in 20 patients with lateonset pompe disease 108
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 108
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 107
A genetic modifier of symptom onset in Pompe disease 107
Chronic migraine in the first COVID‐19 lockdown: the impact of sleep, remote working, and other life/psychological changes 107
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 106
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 105
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 105
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 105
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 105
Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. 104
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 104
A novel mithocondrial tRNAHys point mutation in a patient with PSP-like phenotype. 104
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 104
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 103
A novel Cx32 mutation with unusual phenotype. 103
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 103
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 101
Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection. 101
Isolated Insular Stroke: Clinical Presentation 101
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 100
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 100
Spectrum of movement disorders in mitochondrial diseases 100
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 99
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 99
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 99
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 98
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 98
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 98
Severe rhabdomyolysis in a patient with “Heat Stroke” 98
Clinical and paraclinical indicators of motor system impairment in hereditary spastic paraplegia: A pilot study 97
Role of the cardio-pulmonary exercise test and six-minute walking test in the evaluation of exercise performance in patients with late-onset Pompe disease 97
An unusual association of dominant optic atrophy with OPA1 mutations and parkinsonian syndrome. 96
Acute ischemic stroke due to endocarditis from Brucella infection 96
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 95
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 95
Endocrine myopathies: Clinical and histopathological features of the major forms 95
Management of Teenage Stroke in the Acute Setting: Two Case Reports 95
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 94
Are there ERT defined guidelines for Pompe disease? 94
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa 94
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 94
Totale 12.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.023
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.172 0 0 0 0 0 170 143 217 74 319 168 81
2021/20222.603 19 325 27 133 140 40 240 119 58 204 314 984
2022/20236.264 548 519 299 408 412 589 87 345 2.800 23 171 63
2023/20241.770 138 245 137 140 127 359 24 173 14 153 48 212
2024/20258.636 140 74 135 526 389 303 229 1.592 2.179 472 959 1.638
2025/20269.182 1.139 1.781 2.244 1.846 1.967 205 0 0 0 0 0 0
Totale 34.911